Leiomyosarcoma
Conditions
Interventions
Observation group:None
Sponsors
Zhongshan Hospital affiliated Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1 sign an informed consent form before the start of the study 2 aged 18-70; 3 pathologically diagnosed with LMS; 4 eligible for radical surgery.
Exclusion criteria
Exclusion criteria: Patients meeting any of the following exclusion criteria will not be enrolled in the study: 1 Concurrent active malignant neoplasms other than leiomyosarcoma; 2 Evidence of any severe or uncontrolled systemic disease, including uncontrolled hypertension or active bleeding factors (assessed by the investigator for their 3 potential to reduce the patient’s willingness to participate or compliance with the study treatment regimen), or active infectious diseases such as hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection; 4 Patients deemed ineligible by the investigator, such as those likely to be non-compliant with the study protocol, restrictions, or requirements, or other situations at the investigator’s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence free survival; | — |
Countries
China
Contacts
Public ContactChenlu Zhang
Zhongshan Hospital affiliated Fudan University
Outcome results
None listed